Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet function abnormalities in acute leukaemia

O F Ramos, E C Morón, R De Castro Arenas

    Haematologia
    |December 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Activation and fixation of C3 by human B cell lines is enhanced by interferon-gamma and tumor necrosis factor alpha.

    Complement and inflammation·1991
    Same author

    Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms.

    Cellular immunology·1989
    Same author

    Ligands of CR2 do not interfere with C3 fragment fixation or enhanced NK sensitivity of Raji cells treated with human serum.

    Immunology letters·1989
    Same author

    Requirement of leukocytic cell adhesion molecules (CD11a-c/CD18) in the enhanced NK lysis of iC3b-opsonized targets.

    Journal of immunology (Baltimore, Md. : 1950)·1989
    Same author

    Elevated NK-mediated lysis of Raji and Daudi cells carrying fixed iC3b fragments.

    Cellular immunology·1989
    Same author

    Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targets.

    Journal of immunology (Baltimore, Md. : 1950)·1989
    Same journal

    The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.

    Haematologia·2003
    Same journal

    Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis.

    Haematologia·2003
    Same journal

    Congenital methemoglobinemia due to NADH-methemoglobin reductase deficiency in three Indian families.

    Haematologia·2003
    Same journal

    Angiocentric lymphomatoid granulomatosis and severe hypogammaglobulinaemia.

    Haematologia·2003
    Same journal

    Vena cava superior syndrome due to sternal plasmacytoma in the course of systemic myeloma.

    Haematologia·2003
    Same journal

    Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine.

    Haematologia·2003
    See all related articles

    Platelet function defects are common in acute leukemia, affecting clot retraction and aggregation. Chemotherapy can restore normal platelet function in remission, indicating the leukemia itself causes these issues.

    Area of Science:

    • Hematology
    • Oncology
    • Platelet Biology

    Background:

    • Acute leukemia is a cancer of the blood and bone marrow.
    • Platelets play a crucial role in hemostasis and thrombosis.
    • Leukemia can affect various blood cell lineages, including platelets.

    Purpose of the Study:

    • To investigate in vitro platelet function in patients with acute leukemia.
    • To assess the impact of the leukemic process on platelet behavior.
    • To evaluate changes in platelet function during remission and treatment.

    Main Methods:

    • In vitro studies of platelet function.
    • Analysis of quantitative clot retraction.
    • Assessment of platelet aggregation with various agents.

    Related Experiment Videos

  • Evaluation of platelet factor 3 availability.

    • Main Results:

    • All fourteen patients exhibited abnormal quantitative clot retraction.
    • Platelet aggregation varied depending on the stimulating agent.
    • Platelet factor 3 availability was impaired in six patients.
    • Two patients in complete remission showed near-normal platelet function.
    • One patient with persistent leukemia had worsened platelet function.

    Conclusions:

    • Leukemic platelets exhibit functional defects, including impaired clot retraction and aggregation.
    • These platelet abnormalities are likely a direct consequence of the leukemic process.
    • Achieving remission through chemotherapy can lead to the restoration of normal platelet function.